UNIVERSITY OF SOUTHAMPTON
Faculty of Medicine
Cancer Research UK Senior Lecturer in Medical Oncology
Honorary Consultant in Medical Oncology in Southampton University Hospitals NHS Trust
Particulars of Appointment
The Faculty of Medicine, supported by Cancer Research UK and Southampton University
Hospitals NHS Trust, is seeking a part-time Senior Lecturer in Medical Oncology. This academic
post will function within the Cancer Research UK Centre on the General Hospital campus,
occupying modern, well equipped, purpose-built laboratories in the Somers Building. The
successful candidate will have a strong record of research and publication, and will be expected
to develop their own programme of research with support from clinical and laboratory-based
colleagues, winning support from major national funding bodies, such as CR UK and MRC. We
are particularly seeking candidates with a specialist interest in breast cancer and genetics. It is
expected that the person appointed will contribute to the academic leadership within the
Faculty and enhance the quality of our research, enterprise and teaching. Clinical duties will
enhance the existing practice of the Cancer Care Division in Southampton University Hospitals
NHS Trust in the area of breast cancer.
The University of Southampton is a leading research-intensive University, a member of the
Russell Group and one of the top 100 universities worldwide. We deliver an excellent
educational experience, world-leading research and we are known for successfully
commercialising that research through enterprise.
This is an exciting time to join the University of Southampton. We have an aspirational
University Strategy (see www.southampton.ac.uk/strategy), setting out our ambitions over the
next five years. The strategy involves achieving a top 10 place in the UK for research, which we
will achieve by investing in the highest quality staff and facilities. We are also transforming the
education offer available to undergraduate and postgraduate students across the University,
providing greater flexibility and modular courses, with a strong international focus.
The Faculty of Medicine
The creation of a new Faculty of Medicine has enabled us to build upon strong foundations of
basic research and clinical translation. Working with colleagues across the University and in the
local NHS we have strengthened our position as a renowned centre for translational research,
leading innovative learning and discovery for better health across the lifecourse. In this
context, we are looking to appoint an outstanding senior academic to develop and lead a major
programme of funded clinical research in the field of haematological oncology.
Key to the success of the Faculty of Medicine is the delivery of high-quality education for
undergraduate and postgraduate students, building on our partnership in biomedical research
with Southampton University Hospitals NHS Trust and fostering new collaborations with the
physical sciences, including chemistry, engineering and computing. The new senior academic in
Haematological Oncology will play a key role in these developments.
Research
The Faculty of Medicine has a clear research strategy to investigate the biomedical basis of
common human diseases and to translate this into clinical practice. The Faculty’s research is
delivered through four Academic Units:



Cancer Sciences
Human Development and Health
Infection, Inflammation and Immunity

Primary Care and Population Sciences
All research is organised and managed by these Academic Units, each of which has clear
evidence of international excellence. Each carries a significant degree of devolved
responsibility for its research budgets and grants, space, equipment and personnel.
Working in close partnership with Southampton University Hospitals NHS Trust, translational
research is delivered through the Southampton Centre for Biomedical Research, bringing
together the Cancer Research UK/NIHR Experimental Cancer Medicine Centre, the Wellcome
Trust Clinical Research Facility, the Clinical Trials Unit, two NIHR Biomedical Research Units
(Respiratory, and Nutrition Lifestyle) and shadow Biomedical Research Units in Cardiovascular,
and Bone and Joint Disease
Cancer Sciences
The Cancer Sciences Academic Unit consists of over 150 scientists, clinicians and associated
staff with a research budget in excess of £6m/annum, under the leadership of Professor Martin
Glennie. Southampton was designated a Cancer Research UK Centre in 2008. Core funding
comes from programme grants from Cancer Research UK and Leukaemia and Lymphoma
Research, with major infrastructure support from the Department of Health via the Experimental
Cancer Medicine Centre. . Southampton is a designated Cancer Research UK Centre, with its
own laboratory facilities in the Somers building, adjacent to those of the Human Origins of
Health & Disease group. Both groups have substantial expertise in human genetics, both for
inherited and acquired conditions. The mission of the group has always focused on bringing
together the excellent clinical and basic research within the Faculty of Medicine and delivering
high quality translational research for improving cancer treatment. Our current identified
research strengths focus on cancer immunology and immunotherapy, and the molecular
mechanisms of malignancy including genetic risk and prevention, closely allied to the clinical
practice in cancer treatment within the Southampton Cancer Centre. The academic group, while
based at the General Hospital Campus, has strong collaborative links with the Institute for Life
Sciences on the main University Campus. Within the clinical service there are large, wellorganised multidisciplinary practices in the common malignancies and also in areas of
particular expertise in non-surgical oncology (haematological malignancy, urological cancer,
paediatric malignancy). The strategy of the group is to concentrate on the areas of greatest
potential overlap.
Currently these are:
a. Immunology and Immunotherapy of Cancer
In the Cancer Sciences group we have assembled a team of world-class immunologists
focussed on discovering how tumour cells are recognised by the immune system, how the
immune response fails and how this might be rectified. By fully investigating the complexities
of the immune system and how it interacts with malignant cells, we aim to understand how
tumour cells can be recognised as "foreign" despite their "self" origin, and by using this
information devise new forms of immunotherapy. Current programmes include: initiation of
immune responses to tumour antigens or their suppression (Prof Tim Elliott, Prof Sonia
Quaratino); translation of DNA vaccination into clinical trials (Prof Freda Stevenson, Prof
Christian Ottensmeier); studies of antibodies as modulators of tumour immunity (Prof Martin
Glennie, Prof Peter Johnson, Prof Mark Cragg); regulation of T cell responses by costimulatory
receptors (Prof Aymen Al-Shamkhani) ; delivery of radionuclides by monoclonal antibody
targeting (Dr Kim Orchard).
b. Molecular mechanisms in cancer biology
This group is focussed on understanding the molecular events that contribute to
the inappropriate survival, proliferation, migration and invasion of cancer cells. The long term
goal is to identify key alterations in cancer cells, and to exploit this information to improve the
diagnosis and treatment of cancers. The groups' research interests cover a range of solid and
haematological malignancies, and there are strong interactions between groups lead by
academic and clinical scientists. Professor Graham Packham leads a research group
1
investigating molecular mechanisms controlling proliferation and survival in malignant
lymphocytes, and developing novel chemical compounds to interfere with key cancer promoting
pathways. Professor Gareth Thomas leads a group that studies the regulation of cancer
invasion, with a particular focus on head and neck tumours. The Stress-Response Group is lead
by Dr. Jeremy Blaydes and studies the roles of transcriptional responses to stress-signalling
pathways in the causes and treatment of cancer. Mr. Alexander Mirnezami leads a group
investigating the role of microRNAs in colorectal cancer metastasis, Mr. Ramsey Cutress'
team studies survival proteins in breast cancer, and Mr. Timothy Underwood's group focuses on
oesophageal cancer. Teams with a specific interest in novel therapeutic strategies are lead by
Dr. Andy Davies and Dr. Simon Crabb, who focus on the treatment of lymphoma and
genitourinary maligancies respectively.
c. Cancer Genetics
Investigation of the genetic and cellular basis of malignancy is undertaken by members
of both the Cancer Sciences and Human Origins of Health & Disease groups. The work
encompasses somatically acquired abnormalities as well as inherited factors that predispose to
malignancy.
Familial Cancer Predisposition: There are close links with the NHS Genetics Department,
and Southampton has substantial research in the field of cancer genetics (Prof Diana Eccles,
Prof Anneke Lucassen). Projects currently underway include: a prospective study of outcomes
in early onset breast cancer exploring the implication of genetic factors in young onset breast
cancer treatment outcomes, screening for familial cancer predisposition, and cancer prevention
studies in high genetic risk patients. The CR UK Centre supports an extensive database of
familial cancer patients willing to participate in research.
Haematological Malignancy: Professor Nick Cross is Director of the Wessex Regional
Genetics Laboratory in Salisbury, where Leukaemia and Lymphoma Research funded
programmes into multiple myeloma and myeloproliferative disorders are based. Dr. Jon
Strefford leads The Cancer Genomics Group which focuses on the molecular causes of Chronic
Lymphocytic Leukaemia.
d. Clinical and Translational Research
The Oncology group in Southampton has extensive expertise in translating laboratory
observations into practice and ensuring that the scientific hypotheses underlying the treatments
are properly tested. Last year more than 600 patients entered clinical trials in Southampton, of
whom half were recruited to early phase studies conducted in the Cancer Research UK Clinical
Centre, and half were entered into more than 40 NCRN trials via the Central South Coast Cancer
Research Network. Southampton contributes 40% of patients recruited in the Central South
Coast Network, and the Network in turn recruits over 15% of incident cancer cases to trials.
The tumour bank has been established for 6 years and now contains more than 1000 fresh
frozen specimens with full consent for storage.
There is a broad portfolio of novel therapeutic research, including monoclonal
antibodies, radioimmunotherapy, DNA vaccines, cellular vaccines and small molecules.
In each of these areas there is a significant level of external funding, intergroup
collaboration and publications output. All the research areas derive added value from their
association with the clinical services, either for the provision of pathological material or access
to patients.
Clinical Academic Staff in the Cancer Sciences Division:
Professors:
Professor P W M Johnson MA MD FRCP, Medical Oncology
Professor C H Ottensmeier PhD FRCP, Experimental Cancer Medicine
Professor J N Primrose MD FRCS, Surgical Oncology
Professor D Eccles MD FRCP, Cancer Genetics
Professor A Lucassen DPhil FRCP, Cancer Genetics
Professor G Thomas PhD FDSRCS, Experimental Pathology
2
Senior Lecturers:
Dr A Bateman PhD MRCP FRCR, Clinical Oncology
Dr S Crabb PhD MRCP, Medical Oncology
Mr R Cutress PhD FRCS, Surgical Oncology (Breast)
Dr A Davies PhD MRCP, Medical Oncology
Dr J Gray MA PhD MRCP, Paediatric Oncology
Mrs E V King PhD, FRCS Surgical Oncology (Head and Neck)
Mr A Mirenezami PhD FRCS, Surgical Oncology (Colorectal)
Dr K Orchard PhD FRCP FRCPath, Haematology
Dr A P Williams PhD, MRCP FRCPath, Clinical Immunology
Consultants with Honorary Academic appointments:
Dr M Ashton-Key, DM FRCPath, Histopathology
Dr T J Iveson MD FRCP, Medical Oncology
Dr J Kohler BSc FRCP FRCPCH, Paediatric Oncology
Dr G M Mead DM FRCP, Medical Oncology
Dr P Simmonds FRACP, Medical Oncology
Clinical Cancer Research Infrastructure in Southampton:
There is comprehensive provision for clinical and Translational research in Southampton: This
includes a NIHR accredited Clinical Trials Unit, the Central South Coast Cancer Research
Network for late phase trials, the Cancer Research UK Clinical Research Unit for early phase
trials, the Southampton Experimental Medicine Cancer Centre to support translational research,
and the Wellcome Trust Clinical Research Facility which provides dedicated day-case and inpatient facilities for studies.
Medical Education
We offer a range of undergraduate programmes: the BM4 programme, a graduate-entry fouryear programme which accepts 40 students per year; and the BM5and BMedSc programme
which accepts 200 students per year including approximately 30 students from a BM6
programme aimed at widening access to a medical career. Science teaching in the first three
years of the BM programmes is delivered in the South Block of Southampton General Hospital as
well as the Life Sciences Building on Highfield Campus. Clinical teaching takes place at
Southampton General Hospital and the adjoining Princess Anne Hospital, the Royal South Hants
Hospital, and in NHS Trusts and General Practices throughout Hampshire, Dorset, West Sussex
and Salisbury.
The BM5 programme has a number of distinctive features. These include the integrated nature
of teaching where the scientific disciplines are taught together in a clinical context using a
systems based approach and the BMedSc programme, an eight month supervised research
project undertaken in Year 4. There is also the opportunity, for selected students, to undertake
an integrated, intercalated Masters in Medical Science (MMedSc). The BM4 programme also has
a number of key features. These include clinical topics in the first two years where students
meet on a regular basis in Graduate Groups, and learning with BM5 students in the third and
fourth years on all clinical attachments. All students take the same intermediate and final
examinations. All programmes have substantial clinical experience in the first two years,
student selected components, dispersed final year attachments, work shadowing prior to
commencing a Foundation post and inter-professional learning.
3
In addition to the undergraduate BM programmes the School provides two Masters Degree
programmes in Public Health Nutrition and Allergy.
Relationships with the National Health Service
Southampton University Hospitals NHS Trust (SUHT)
The Trust provides acute healthcare services for Southampton area (population 550,000). This
covers an area bordering on the Solent and extending to the boundary of Winchester in the
north, the Wiltshire border in the west and the River Hamble in the east. In addition, many
specialist services are provided to a much wider area extending to Chichester, Portsmouth,
Winchester, Basingstoke, Salisbury, Bournemouth and Poole, Dorchester, the Isle of Wight and
the Channel Islands. These include the defining services of the Trust in cancer, neurosciences,
respiratory, gastrointestinal, women and children and cardiothoracic. Southampton forms one
of the two teaching hospitals in the South Central Health Authority Region and, as a CalmanHine Regional Cancer Centre, provides comprehensive cancer services for a large population of
3+ million.
Southampton General Hospital (SGH) – 1,200 beds.
Princess Anne Hospital – (PAH) 124 beds.
The Cancer Care Group at SUHT
The Cancer Care Group is part of the Surgical and Cancer Services Division and is formed by the
Departments of Haematology, Medical Oncology, Clinical Oncology and Palliative Care. A new
Macmillan Cancer Information Centre opened adjacent to the Oncology Centre in June 2005.
The Southampton Oncology Centre provides comprehensive cancer services to a local
population of approximately 1.7 million and fulfils the criteria for a stand-alone Cancer Centre
as described in the document “Policy Framework for Commissioning of Cancer Services”. The
Centre provides a high degree of specialisation with multidisciplinary clinics for all the major
cancers. Phases I and 2a of the redevelopment of the Oncology Centre have been completed
with the opening of new inpatient facilities for Medical Oncology, Clinical Oncology and
Malignant Haematology at Southampton General Hospital, together with a new day unit and
chemotherapy clinic with a dedicated oncology pharmacy incorporating an aseptic unit. Current
radiotherapy facilities on this site include a planning suite, with a conventional simulator-CT
and a dedicated wide-bore CT for virtual simulation. There are currently six multimodality linear
accelerators with portal imaging and multileaf collimation [two with beam modulation], one of
which has IGRT capability. The department also houses the deep/superficial unit, the Oncology
X-ray Department with a multislice CT scanner for diagnostic use and the Clinical Oncology
ward and office accommodation.
At present, Medical Oncology patients are located in a separate ward on the SGH site.
Haematology in-patient services are also located on the SGH site, offering 16 beds, with 6
supporting transplant services (3 with full air filtration). All Cancer Care in-patient services are
located at the General Hospital 58 beds in total.
Paediatric Oncology patients are managed in Piam Brown Ward, which is a specialist unit,
dedicated solely to the care of children with cancer. It has 10 inpatient beds and 4 day case
beds. There is an outpatient area with two consulting rooms, an anaesthetic room for minor
procedures, a school and facilities for parents. Haematological malignancies, solid tumours and
CNS tumours are all managed in this regional unit and high dose chemotherapy/autografts are
also performed in house.
Referrals to the Unit are from Consultants within Southampton from the surrounding districts
within the South and West Region, and also directly from family practitioners. The Unit has a
direct or indirect involvement on a regular basis with many parts of the Region. Consultants in
4
Oncology are involved with peripheral clinics at one or more hospitals so that the Unit is
involved in the provision of cancer services in the following hospitals: Portsmouth, Guernsey,
Jersey, The Isle of Wight, Basingstoke, Salisbury, Winchester.
Wessex Clinical Genetics Service
The Wessex Clinical Genetics Service is based at the Princess Anne Hospital and covers a
population of 2.7 million people encompassing Hampshire, Isle of Wight, Dorset and South
Wiltshire. The clinical service is fully integrated with the molecular diagnostic service provided by
the Wessex Regional Genetics Laboratory in Salisbury (Director Professor Nick Cross). The Human
Genetics Research Group sits within the Academic Unit of Human Origins of Health and Disease
within the University of Southampton school of medicine. The Cancer Genetics clinical service is
one of the longest established in the UK and remains a focus for leadership and training nationally
and internationally. Links between the Cancer Genetics, Human Genetics and Cancer Sciences
particularly benefit from a growing Bioinformatics research group lead by Professor Andy Collins
and Dr Sarah Ennis with interests in Genome Wide disease Assication studies and growing expertse
in analysis of whole genome sequencing data. There are also strong links with Law and Ethics in
the wider university.
There are, five NHS consultants in clinical genetics including Dr A L Collins (Head of Service), Dr
N Foulds, Dr K Lachlan, Dr D Baralle, Dr D Wellesley and three University members of the clinical
staff (honorary NHS consultants) Prof DM Eccles, Prof AL Lucassen and Prof IK Temple. There
are four Specialist Registrar training numbers associated with the department, two currently
occupied by ACFs. There are fourteen specialist genetic nurse counsellors and eight clerical
officers.
Hampshire Partnership Trust
The Trust is a specialist mental health trust providing services to adults of working age, the
elderly and adolescents and to people with learning disabilities. It has sites throughout
Hampshire many of which are equipped for teaching. It also has major research activities in
adult psychiatry based at the Royal South Hants and Old Age Psychiatry at Moor Green Hospital.
Primary Care Trusts
The School of Medicine has good relationships with PCTs in Southampton and Hampshire and is
actively exploring ways of working together academically.
Portsmouth Hospitals NHS Trust and the Royal Hampshire County Hospital, Winchester
A substantial amount of undergraduate education takes place at the Queen Alexandra Hospital
in Cosham and St Mary’s Hospital, Portsmouth. Expansion of undergraduate education activity
has also taken place at the Royal Hampshire County Hospital, Winchester.
Staffing in Medical Oncology
Professors
Professor P W M Johnson MA MD FRCP
Professor C Ottensmeier PhD, FRCP,
Consultants:
Dr J. Cave MD MRCP, NHS Consultant
Dr E. Copson PhD MRCP, NHS Consultant
Dr S. Crabb PhD MRCP, CR UK Senior Lecturer
Dr A. Davies PhD, MRCP, CR UK Senior Lecturer
Dr T. Dhillon, MB BS MRCP, NHS Consultant
Dr C. Green BSc MB BS MRCP, NHS Consultant
Dr T. Iveson MD FRCP, MacMillan NHS Consultant, Hon Senior Lecturer
Dr G. Mead DM FRCP, NHS Consultant, Hon Senior Lecturer
Dr L. Nolan, PhD MRCP, NHS Consultant
Dr C. Rees MD MRCP, NHS Consultant
Dr P. Simmonds MB BS FRACP, NHS Consultant, Hon Senior Lecturer
6 Specialist Registrars in Medical Oncology and 2 Clinical Fellows
5
Clinical interests in Medical Oncology:
Professor Johnson
Lymphoma
Professor Ottensmeier
Lung cancer and melanoma
Dr Cave
Lung and Gastrointestinal cancer
Dr Copson
Breast cancer
Dr Crabb
Urologic cancer
Dr Davies
Lymphoma and high dose therapy
Dr Dhillon
Lung and Gastrointestinal cancer
Dr Green
Gynaecology and lung cancer
Dr Iveson
Gastrointestinal cancer
Dr Mead
Urologic cancer
Dr Rees
Gastrointestinal cancer
Dr Simmonds
Breast cancer and sarcoma
CR UK Clinical research staff
Sr J Tambellini, CR UK Senior Research Nurse
Research Nurses
8
Clinical Trials Associate
1
IT Officer
1
Central South Coast Cancer Research Network
Ms J Walters, Network Manager
Mrs J Gwilt, Network Administrator
Clinical Trials Practitioners
12
Clinical Trials Unit
Director: Prof Diana Eccles MD FRCP
Associate Director of Operations: Ms E Moore
Senior statistician: Ms L Dent MSc
Senior Clinical Trials Managers
2
Clinical Trials Managers
3
Contracts and Regulatory staff
2
Data Managers
2
Programmer
1
Unit administrator
1
Clinical Trials Support staff
14
Principal Duties
The post will comprise 2 clinical and 3 academic programmed activities (PAs). Protected time
for maintenance of Continuing Medical Education and Continuing Professional Development, as
recommended by the Royal Colleges of Physicians and Radiologists, will be split between the
two components for a total of 1PA. Each PA has a timetable value of 4 hours and each PA may
include a combination of duties.
This post will allow enhancement of site specialised multi-disciplinary working in breast cancer.
The service aspects of the post will cover the treatment of patients in support of the existing
consultant team and the post-holder will not be expected to develop an independent clinical
practice. The post will enhance the quality of service through increased consultant input in
clinics and at multi-disciplinary meetings, and will develop the portfolio of clinical research in
the genetic aspects of breast cancer.
The post-holder will participate in the out of hours consultant cover rota pro-rata. The postholder and other consultant colleagues will be expected to cover each other’s absences on
annual or study leave as far as is practicable.
Training Duties
6
The post-holder will have responsibility for the training and supervision of staff who work with
them and they will devote time to this activity on a regular basis.
Many students spend their final year module attached to Oncology. The post-holder may be
required to undertake some ward teaching of medical students and training of junior medical
staff in preparation for the MRCP examination. In addition, the Unit has responsibility for Year 4
studies in depth, the scientific basis of medicine course and the Year 3 oncology module.
He/she will be expected to assist in these teaching activities. A course in Oncology for qualified
nurses is conducted biennially and he/she will be involved in the programme of lectures for this
course. Frequent postgraduate meetings and medical grand rounds take place to which the Unit
regularly contributes and he/she will be expected to participate in these.
Management Duties
Southampton General Hospital established a Clinical Management System in 1986, which was
extended throughout the Southampton University Hospitals in 1991. Clinical academic staff are
managerially accountable for their clinical duties to the Clinical Lead, who has overall
responsibility for the services within the Care Group. The post-holder will have managerial
responsibility for the processes in the ambulatory care centre, in collaboration with the Care
Group management team.
Administrative Duties
The post-holder will be required to undertake the administrative duties associated with the care
of patients and the running of the clinical department. There is a full secretarial staff in
Oncology to which the post-holder will have access. Shared office accommodation will be
provided within the Oncology department.
The post-holder will be required to:
i.
undertake the administrative duties associated with the care of patients and the running
of clinical departments.
ii.
travel as necessary between Units.
Clinical Audit
The post-holder will participate in the clinical audit programme of the Directorate as required.
Other Duties
From time to time it may be necessary for the post-holder to carry out such other duties as may
be assigned, with agreement, by the Trust. It is expected that the post-holder will not
unreasonably withhold agreement to any proposed changes.
Weekly Timetable
This timetable is indicative, and may be amended according to the development of the service
by agreement with the Care Group clinical lead. Provision of time for Continuing Professional
Development and revalidation will be made flexibly, divided between clinical and academic
time.
All clinical duties will be in Southampton
Day
Monday
AM Duties
No duties
PM Duties
No duties
Tuesday
(2 PA)
Wednesday
(2 PA)
Thursday
(1 PA)
Friday
Ward meeting/Round
Early Breast Cancer Clinic
Breast Cancer MDT (cover)
Research/CPD/Revalidation
Reserved for Research
Breast Focus Group/ Journal Club
Advanced Breast Cancer Clinic
Patient Administration/Research
No duties
No duties
No duties
7
Weekly Duties
The minimum average number of PA spent each week on the duties associated with this post
are as follows:
Out-patients/Chemotherapy
MDT meetings
Teaching/Training
Research
Administration
Continuing Professional Development/Revalidation
1.0
0.2
0.1
2.5
0.2
1.0
Terms of Appointment
1.
The appointment will be governed by the general conditions applicable to clinical
academic staff in the University of Southampton; details of these are available on request and
will be sent to candidates called for interview. The appointee will be subject to the relevant
terms of appointment as determined by the appropriate NHS Trust, in connection with his/her
clinical duties in so far as they may apply to clinical academic staff holding honorary NHS Trust
contracts. The appointee will be responsible to the Head of the School of Medicine through the
Divisional Director for the satisfactory conduct of his/her duties.
2.
The successful candidate will be expected to take up their appointment as soon as
possible. The appointment may be subject to a probationary period of up to three years.
3.
The appointment will be made within the Clinical Academic (Honorary Consultant) salary
scale (£71,822 - £96,831 per annum pro rata), depending on qualifications and experience.
4.
The appointment may be terminated by a semester’s notice on either side.
In addition to your substantive contract of employment with the University, you will also hold an
honorary NHS contract with an NHS Trust and are required to be registered with the General
Medical Council. This honorary contract and registration is essential for the proper
performance of the duties of your employment with the University. In the event that the
honorary contract is terminated or the registration is revoked or suspended, your continued
employment with the University under this contract will need to be reviewed and may be
terminated. The procedure for considering whether to terminate your substantive contract of
employment with the University in such circumstances is set out in the University’s Statutes and
Ordinances from time to time in force and in a protocol between the University and the NHS
Trust. You will be required during your tenure of office to undertake appropriate clinical work
on an honorary basis under the National Health Service. No professional contact with National
Health Service patients may be undertaken unless a duly authorised honorary contract has been
issued to you and is currently valid.
6.
The appointee will be subject to joint annual appraisal between the University and the
relevant NHS Trust.
7.
The actual cost of removal of personal and household effects and/or incurred legal costs
for the purchase of a house or flat in or near Southampton will be paid by the University subject
to a maximum contribution of £4500. The purchase of such a house or flat must be as a
consequence of taking up the appointment and the claim must normally be submitted within
twelve months of taking up the post.
8.
The person appointed will be required to observe the Charter, Statutes and Ordinances
of the University and to carry out all orders and regulations of the Council. It should be noted
8
that these regulations include a policy of no smoking at work which, with the exception of
certain designated areas, prohibits smoking in most University buildings.
9.
The person appointed will be expected to work within the spirit and letter of the
University's Equal Opportunities Policy:
"The University of Southampton confirms its commitment to a comprehensive policy of
equal opportunities in employment and for students in which individuals are selected and
treated on the basis of their relevant merits and abilities and are given equal opportunities
within the University. The aim of the policy is to ensure that no job applicant or employee,
prospective student or student, should receive less favourable treatment on any grounds which
are not relevant to good employment practice for staff or to academic ability and attainment for
students. The University is committed to a programme of action to make the policy fully
effective."
Because of the nature of the work for which you are applying, this post is exempt from the
provisions of Section 4(2) of the Rehabilitation of Offenders Act 1974 by virtue of the
Rehabilitation of Offenders Act 1974 (Exceptions) Order 1975. Applicants are, therefore, not
entitled to withhold information about convictions and, in the event of employment, any failure
to disclose such convictions could result in dismissal or disciplinary action by the University.
The University will routinely conduct checks on criminal records for all those appointed to posts
that have contact with children or vulnerable adults. Any information given will be completely
confidential and will be considered only in relation to an application for positions to which the
order is applied.
Applicants should send a full curriculum vitae (5 copies from UK applicants, 1 from overseas),
including the names and addresses of three referees to the Human Resources Department (M),
University of Southampton, Highfield, Southampton SO17 1BJ no later than 30/06/11.
Please quote reference number 011811CM.
9